Epidemiology and control of human gastrointestinal parasites in children

Michael O Harhay1, John Horton, Piero L Olliaro

  • 1Graduate Group in Demography, Population Studies Center, University of Pennsylvania, 239 McNeil Building, 3718 Locust Walk, Philadelphia, PA 19104-16298, USA. harhay@pop.upenn.edu

Insights

Soil-transmitted helminths infect one-sixth of the global population, primarily children in low-income regions. Despite mass drug administration, many remain untreated, facing challenges like funding and drug resistance.

Area of Science:

  • Global Health
  • Infectious Diseases
  • Parasitology

Background:

  • Gastrointestinal parasites, including protozoa and helminths, disproportionately affect children in sub-Saharan Africa, Asia, and Latin America.
  • Soil-transmitted helminths (STH) like Ascaris lumbricoides, hookworm, and Trichuris trichiura are the most prevalent, impacting an estimated one-sixth of the global population.
  • Mass drug administration (MDA) programs, often school-based, have significantly increased anthelmintic drug delivery to children.

Purpose of the Study:

  • To review the impact of major gastrointestinal protozoa and helminths on child health.
  • To discuss the changing epidemiology of these infections.
  • To analyze the relationship between epidemiology and control strategies.

Main Methods:

  • Literature review of gastrointestinal protozoa and helminths.
  • Analysis of epidemiological data and infection rates in children.
  • Evaluation of current control strategies, including mass drug administration.

Main Results:

  • MDA programs have delivered substantial quantities of anthelmintics but a large untreated population remains.
  • Significant challenges hinder control efforts, including insufficient funding for research, drug procurement, and supply chain sustainability.
  • Concerns exist regarding limited chemotherapy options, potential drug resistance due to overuse, and inadequate health infrastructure for monitoring.

Conclusions:

  • While MDA is a powerful tool, substantial funding and resources are required to expand treatment coverage and address the growing untreated population.
  • Developing novel treatments and second-line options is crucial to combat potential drug resistance.
  • Strengthening health infrastructures is essential for effective pharmaco-epidemiology and monitoring of drug resistance.

Related Concept Videos

Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...